gSpin Technologies develops quantum‑enhanced medical hardware, including MRI coils that boost signal‑to‑noise ratio to enable faster, higher‑resolution imaging and more compact, point‑of‑care scanners. It also creates a contactless tabletop blood analysis device that provides real‑time metabolic data without venipuncture, improving patient comfort and diagnostic speed.
Funding
$1B raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conventional MRI systems are limited by low signal-to-noise ratios, leading to long scan times, bulky equipment, and high costs, which restrict access to high-quality imaging. Traditional blood diagnostics require invasive venipuncture, causing patient discomfort, limiting screening frequency, and delaying timely clinical decisions.
Solution
gSpin Technologies applies quantum-enhanced sensing to create next‑generation medical hardware that addresses these limitations. Their quantum‑boosted MRI coils deliver markedly higher signal‑to‑noise performance, enabling faster acquisitions, higher contrast, and finer spatial resolution without extending scan time. The improved signal also allows the design of more compact, cost‑effective MRI units tailored for specific applications such as breast or liver imaging, facilitating point‑of‑care deployment. In parallel, gSpin is developing a tabletop, contactless blood analysis device that uses quantum sensing to provide real‑time metabolic data without drawing blood, aiming to simplify screening and support rapid clinical decision‑making across acute and chronic care settings.
Target Audience
Primary customers include hospitals, imaging centers, and specialty clinics seeking faster, higher‑quality MRI scans, as well as point‑of‑care facilities, urgent care centers, and primary care practices that require non‑invasive, rapid blood diagnostics.
Features
- Quantum‑enhanced MRI coil technology that increases signal‑to‑noise ratio for high‑field scanners
- Ability to reduce MRI acquisition time while maintaining or improving image quality
- Enhanced image contrast and spatial resolution options without additional scan duration
- Compact, purpose‑built MRI system designs for targeted applications (e.g., breast, liver) to enable point‑of‑care imaging
- Contactless, tabletop blood diagnostic platform that performs real‑time metabolic measurements without venipuncture
- Quantum sensing‑driven detection of biomarkers relevant to metabolic, cardiovascular, and infectious diseases
- Designed for rapid, on‑site health assessments to improve patient comfort and screening accessibility